Analyst Views: Changes for L'Oréal, Kering, Safran...

Above their target: 8 securities · SBF 120 covered securities: 120

Securities above their target: Rémy Cointreau (-17.4%) · Teleperformance (-16.5%) · Eurofins Scientific (-14.9%) · bioMérieux (-10.8%) · Sodexo (-9.6%) · Dassault Systèmes (-4.5%) · Euronext (-1.5%) · Worldline (-1.1%)

L'Oréal: eight brokers raise their target following the company's third-quarter results. BNP Paribas Exane raises from 460 to 500 euros (outperform), Citi from 435 to 470 euros (buy), UBS from 440 to 465 euros while maintaining buy, CIC Market Solutions from 420 to 460 euros, also maintaining buy. Goldman Sachs (buy) moves from 435 to 450 euros, Bernstein (market perform) from 405 to 420 euros, Oddo BHF (neutral) from 398 to 417 euros and Morgan Stanley (overweight) from 379 to 414 euros. One analyst had raised their target on October 19. Median target at 439.50 euros, Target/price gap: +1.8%.

At Kering, the session features successive cuts. Barclays reduces its target from 300 to 230 euros, CIC Market Solutions from 300 to 270 euros (maintaining buy), Morgan Stanley from 250 to 220 euros (equal-weight), Goldman Sachs from 250 to 230 euros (neutral) and TD Cowen from 235 to 210 euros (hold). Jefferies moves from 220 to 200 euros (hold), JP Morgan from 215 to 200 euros (underweight), Oddo BHF from 248 to 240 euros (neutral) and UBS from 224 to 219 euros, maintaining "hold". Three analysts had already lowered their targets over the past 10 days, the last on October 16. Median at 243 euros, Target/price gap: +29%.

On Hermès International, Berenberg makes the sharpest cut: from 1,850 to 1,230 euros, with rating downgraded from "buy" to "hold". MedioBanca (neutral) moves from 2,100 to 1,800 euros, Bernstein (outperform) from 1,750 to 1,480 euros, RBC Capital (sector perform) from 1,600 to 1,500 euros and UBS, maintaining "sell", from 1,168 to 1,150 euros. Barclays also adjusts its target, from 1,660 to 1,570 euros. Two analysts had lowered their targets over the past 10 days, the last on October 22. Median at 1,600 euros, Target/price gap: +27.2%.

From 135 to 139 euros: that is what Kepler Cheuvreux sets for EssilorLuxottica. Three analysts had raised and six lowered their targets over the past 10 days, the last movement dating from October 22. Median at 217.50 euros, Target/price gap: +21.6%.

OVH sees its target jump from 9.50 to 16.50 euros at Kepler Cheuvreux, which maintains "hold". One analyst also raised their target on October 22. The median stands at 18.75 euros, Target/price gap: +52.7%.

On the Carrefour side, Kepler Cheuvreux moves from "buy" to "hold" and reduces its target from 18.50 to 16.10 euros. Ten analysts had lowered their target over the past 10 days, against just one raising it, the last movement dating from October 22. Median at 15.40 euros, Target/price gap: +11.1%.

For BE Semiconductor Industries, BofA Securities cuts its target: from 212 to 175 euros, with rating unchanged at "hold". Two analysts had lowered their targets, the last on October 19. Median at 250 euros, Target/price gap: +68%.

Schneider Electric: BofA Securities maintains buy and reduces its target from 367 to 356 euros. Five analysts had lowered and two raised their targets over the past 10 days, the last movement dating from October 21. Median at 326 euros, Target/price gap: +40.2%.

From 32 to 35 euros at Bureau Veritas: the movement comes from BofA Securities. Two analysts had raised their targets over the past 10 days, the last on October 22. Median at 34 euros, Target/price gap: +18.1%.

Still maintaining "sell", BofA Securities raises its target by one euro on Eurofins Scientific, from 60 to 61 euros. Two analysts had raised their targets, the last on October 22. Median at 70.45 euros, Target/price gap: -14.9%.

Michelin: Intesa Sanpaolo, maintaining "hold", revises its target from 35 to 33 euros. Four analysts had lowered their targets over the past 10 days, the last on October 21. Median at 34.50 euros, Target/price gap: +9.9%.

At Solvay, Kepler Cheuvreux, maintaining "hold", reduces its target from 27 to 25 euros. One analyst had lowered theirs on October 20. Median at 25.70 euros, Target/price gap: +10%.

From 11.50 to 10 euros: Sligro Food Group sees its target lowered by ING Wholesale, which maintains "hold". One analyst had lowered their target on October 16. Median at 9.75 euros, Target/price gap: +7.3%.

Flow Traders: maintaining "hold", ING Wholesale raises its target from 25.89 to 27.68 euros. Median at 29 euros, Target/price gap: +14.9%.

On Safran, CIC Market Solutions maintains buy with target unchanged at 378 euros. One analyst had raised their target on October 16. Median at 384 euros, Target/price gap: +39%.

For Vinci, CIC Market Solutions, with buy rating, leaves its target at 141 euros, while Oddo BHF (outperform) reduces it from 155 to 150 euros. Two analysts had lowered their targets over the past 10 days, the last on October 20. Median at 146.25 euros, Target/price gap: +38%.

Accor: CIC Market Solutions confirms its buy and leaves its target at 51 euros. One analyst had raised their target on October 21. Median at 54 euros, Target/price gap: +20.5%.

At High Co, Invest Securities maintains buy with target of 4.60 euros, unchanged. One analyst had lowered their target on October 22. Median at 4.60 euros, Target/price gap: +32.4%.

Voltalia: Invest Securities, with buy rating, keeps its target at 10.60 euros, while TP Icap Midcap (hold) reduces it from 6.90 to 5.50 euros. One analyst had lowered their target on October 13. Median at 6.95 euros, Target/price gap: +66.9%.

At 45 euros, Euroland Corporate's target on Sword Group remains unchanged, the broker maintaining buy. Median at 44 euros, Target/price gap: +40.6%.

Wendel: Euroland Corporate, maintaining buy, keeps its target at 109 euros. Median at 115 euros, Target/price gap: +41%.

Two cuts on Pullup Entertainment, both with buy rating: Portzamparc moves from 16.80 to 13.80 euros, TP Icap Midcap from 21 to 19 euros. Median at 16.50 euros, Target/price gap: +141.6%.

At Pierre Vacances, TP Icap Midcap is at "hold" with target reduced from 2.30 to 1.90 euro. Median at 2 euros, Target/price gap: +7.3%.

Groupe Guillin: TP Icap Midcap shows target of 27 euros, buy rating. Median at 28.50 euros, Target/price gap: +43.9%.

From 16 to 20 euros at Ateme: TP Icap Midcap, with buy rating, raises its target. Median at 20.15 euros, Target/price gap: +86.6%.

Portzamparc, with buy rating, adjusts several targets downward and one upward:
for Groupe SEB, from 94 to 87 euros (median at 79.25 euros, Target/price gap: +45.8%);
for Roche Bobois, from 33 to 27 euros (median at 26 euros, Target/price gap: +103.9%);
for Lisi, from 77 to 78 euros (median at 75 euros, Target/price gap: +27.8%). One analyst had lowered their target on Lisi on October 13.

Thales: Oddo BHF, with outperform rating, adjusts its target from 288 to 287 euros. One analyst had raised their target on October 22. Median at 287 euros, Target/price gap: +26.7%.

On the Getlink side, Morgan Stanley (overweight) raises its target from 20.30 to 21.50 euros. Two analysts had raised and one lowered their targets over the past 10 days, the last movement dating from October 22. Median at 19.83 euros, Target/price gap: +1.5%.

At Aperam, two targets decline: Citi (neutral) moves from 50 to 42 euros, Morgan Stanley (equal-weight) from 52 to 46 euros. Two analysts had lowered their targets, the last on October 16. Median at 47 euros, Target/price gap: +32.5%.

Sartorius Stedim Biotech: Goldman Sachs, with buy rating, raises its target from 223 to 235 euros. Median at 240 euros, Target/price gap: +13.5%.

Goldman Sachs, with buy rating, also raises two other targets:
for Rexel, from 43 to 46 euros, while Oxcap Analytics (overweight) moves from 41.60 to 42.60 euros (median at 43.30 euros, Target/price gap: +33.1%; one analyst had raised their target on October 16);
for Covivio, from 51 to 53.10 euros (median at 55.05 euros, Target/price gap: +25.2%; one analyst had lowered their target on October 22).

KBC: Citi moves from "neutral" to "buy" and yet reduces its target from 140 to 136 euros. Three analysts had lowered their targets over the past 10 days, the last on October 21. Median at 136.50 euros, Target/price gap: +21.6%.

On the UCB side, two increases: BNP Paribas Exane (outperform) moves from 312 to 330 euros, Jefferies (hold) from 220 to 250 euros. One analyst had lowered their target on October 20. Median at 260 euros, Target/price gap: -1%.

Compagnie des Alpes: Bernstein, with outperform rating, reduces its target from 30.20 to 25.10 euros. Median at 25.55 euros, Target/price gap: +49.9%.

From 75 to 85 euros at bioMérieux: the movement comes from RBC Capital. Median at 79 euros, Target/price gap: -10.8%.

Tikehau Capital: RBC Capital is at "sector perform", target 16 euros. One analyst had lowered their target on October 13. Median at 20.70 euros, Target/price gap: +32.9%.

HSBC tightens two targets:
on Stellantis, from 4 to 3.30 euros, rating "reduce" (median at 5.10 euros, Target/price gap: +36.8%; two analysts had lowered their targets, the last on October 16);
on Engie, from 29.60 to 27.20 euros, rating "hold" (median at 30 euros, Target/price gap: +30.9%; one analyst had lowered their target on October 22).

Finally, Nexans: Barclays, with overweight rating, raises its target from 181 to 183 euros. One analyst had raised their target on October 22. Median at 172.50 euros, Target/price gap: +51.4%.